메뉴 건너뛰기




Volumn 21, Issue 5, 2003, Pages 383-391

Changing paradigms in dermatology: Topical immunomodulators within a permutational paradigm for the treatment of atopic and eczematous dermatitis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; BARBITURIC ACID DERIVATIVE; CAPTOPRIL; CARBAMAZEPINE; CHLORPROPAMIDE; CIMETIDINE; CORTICOSTEROID; CYCLOSPORIN; DERMATOLOGICAL AGENT; FUROSEMIDE; GOLD; IMMUNOMODULATING AGENT; ISONIAZID; LITHIUM; METHYLDOPA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENYTOIN; PIMECROLIMUS; QUINAZOLINE; QUINIDINE; SEDATIVE AGENT; TACROLIMUS; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG;

EID: 0346996351     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.08.013     Document Type: Article
Times cited : (22)

References (52)
  • 1
    • 0003396541 scopus 로고    scopus 로고
    • Montvale, NJ: Medical Economics Company, Inc.
    • Drug Topics Red Book. Montvale, NJ: Medical Economics Company, Inc. 2001.
    • (2001) Drug Topics Red Book
  • 2
    • 85030918439 scopus 로고    scopus 로고
    • Fujisawa Healthcare, Inc., Data on File
    • Fujisawa Healthcare, Inc., Data on File.
  • 5
    • 0035153766 scopus 로고    scopus 로고
    • Cellular and immunologic mechanisms in atopic dermatitis
    • Leung D.Y.M., Soter N.A. Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol. 44:2001;S1-12.
    • (2001) J Am Acad Dermatol , vol.44 , pp. 1-12
    • Leung, D.Y.M.1    Soter, N.A.2
  • 6
    • 0035098344 scopus 로고    scopus 로고
    • So moisturizers cause trouble!
    • Held E. So moisturizers cause trouble! Intl J Dermatol. 40:2001;12-13.
    • (2001) Intl J Dermatol , vol.40 , pp. 12-13
    • Held, E.1
  • 7
    • 85030926705 scopus 로고    scopus 로고
    • Yamanouchi, the Netherlands
    • SBR-Lipocream, Yamanouchi, the Netherlands.
    • SBR-Lipocream
  • 8
    • 85030927937 scopus 로고    scopus 로고
    • DPT Laboratories, Ltd., San Antonio, Texas
    • TheraSeal, DPT Laboratories, Ltd., San Antonio, Texas.
    • TheraSeal
  • 9
    • 8944227498 scopus 로고    scopus 로고
    • Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function
    • Rawlings A.V., Davies A., Carlomusto M., et al. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res. 288:1996;383-390.
    • (1996) Arch Dermatol Res , vol.288 , pp. 383-390
    • Rawlings, A.V.1    Davies, A.2    Carlomusto, M.3
  • 10
    • 0030048080 scopus 로고    scopus 로고
    • Urea-containing moisturizers influence barrier properties of normal skin
    • Loden M. Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res. 288:1996;103-107.
    • (1996) Arch Dermatol Res , vol.288 , pp. 103-107
    • Loden, M.1
  • 11
    • 0027717157 scopus 로고
    • Efficacy and safety of emollients as adjunctive agents in topical corticosteroid therapy for atopic dermatitis
    • Kantor I., Milbauer J., Posner M., et al. Efficacy and safety of emollients as adjunctive agents in topical corticosteroid therapy for atopic dermatitis. Today Ther Trend. 11:1993;157-166.
    • (1993) Today Ther Trend , vol.11 , pp. 157-166
    • Kantor, I.1    Milbauer, J.2    Posner, M.3
  • 13
    • 0031881256 scopus 로고    scopus 로고
    • Percutaneous sensitization with mite antigens elicits a TH-2 dominant cytokine response in a cutaneous barrier-disrupted model
    • Kondo H., Ichikawa Y., Imokawa G. Percutaneous sensitization with mite antigens elicits a TH-2 dominant cytokine response in a cutaneous barrier-disrupted model. Eur J Immunol. 28:1998;769-779.
    • (1998) Eur J Immunol , vol.28 , pp. 769-779
    • Kondo, H.1    Ichikawa, Y.2    Imokawa, G.3
  • 14
    • 0031002911 scopus 로고    scopus 로고
    • Skin disorders in ship's engineers exposed to oils and solvents
    • Svendsen K., Hilt B. Skin disorders in ship's engineers exposed to oils and solvents. Contact Dermat. 36:1997;216-220.
    • (1997) Contact Dermat , vol.36 , pp. 216-220
    • Svendsen, K.1    Hilt, B.2
  • 15
    • 0035021315 scopus 로고    scopus 로고
    • Utility of food-specific IgE concentrations in predicting symptomatic food allergy
    • Sampson H.A. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol. 107:2001;891-906.
    • (2001) J Allergy Clin Immunol , vol.107 , pp. 891-906
    • Sampson, H.A.1
  • 16
    • 0028828520 scopus 로고
    • Breast feeding as prophylaxis against atopic disease: Prospective follow up study until 17 years old
    • Saarinen U.M., Kajosaari M. Breast feeding as prophylaxis against atopic disease prospective follow up study until 17 years old . Lancet. 346:1995;1065-1069.
    • (1995) Lancet , vol.346 , pp. 1065-1069
    • Saarinen, U.M.1    Kajosaari, M.2
  • 17
    • 0024976425 scopus 로고
    • Influence of maternal diet during lactation and use of formula feed on development of atopic eczema in high risk infants
    • Chandra R.K., Shakuntia P., Hamed A. Influence of maternal diet during lactation and use of formula feed on development of atopic eczema in high risk infants. BMJ. 299:1989;228-230.
    • (1989) BMJ , vol.299 , pp. 228-230
    • Chandra, R.K.1    Shakuntia, P.2    Hamed, A.3
  • 18
    • 0024240920 scopus 로고
    • Double-blind placebo-controlled food challenge as an office procedure: A manual
    • Bock S.A., Sampson H.A., Atkins F.M., et al. Double-blind placebo-controlled food challenge as an office procedure a manual . J Allergy Clin Immunol. 82:1988;986-997.
    • (1988) J Allergy Clin Immunol , vol.82 , pp. 986-997
    • Bock, S.A.1    Sampson, H.A.2    Atkins, F.M.3
  • 19
    • 0035820307 scopus 로고    scopus 로고
    • Probiotics in primary prevention of atopic disease randomized placebo-controlled trial
    • Kalliomaki M., Salminen S., Arvilommi H., et al. Probiotics in primary prevention of atopic disease randomized placebo-controlled trial. Lancet. 357:2001;1057-1059.
    • (2001) Lancet , vol.357 , pp. 1057-1059
    • Kalliomaki, M.1    Salminen, S.2    Arvilommi, H.3
  • 20
    • 0030053474 scopus 로고
    • Double blind controlled study of the effect of house dust-mite allergen avoidance on atopic dermatitis
    • Tam B., Weald D., Strickland I., et al. Double blind controlled study of the effect of house dust-mite allergen avoidance on atopic dermatitis. Lancet. 347:1966;15-18.
    • (1966) Lancet , vol.347 , pp. 15-18
    • Tam, B.1    Weald, D.2    Strickland, I.3
  • 21
    • 0023195234 scopus 로고
    • Itching from wool fibres in atopic dermatitis
    • Bendsoe N., Bjomberg A., Asnes H. Itching from wool fibres in atopic dermatitis. Contact Dermat. 17:1987;21-22.
    • (1987) Contact Dermat , vol.17 , pp. 21-22
    • Bendsoe, N.1    Bjomberg, A.2    Asnes, H.3
  • 22
    • 0034918875 scopus 로고    scopus 로고
    • Psychological approach to atopic skin disease
    • Staughton R. Psychological approach to atopic skin disease. J Am Acad Dermatol. 45:2001;S553-554.
    • (2001) J Am Acad Dermatol , vol.45 , pp. 553-554
    • Staughton, R.1
  • 23
    • 0034486281 scopus 로고    scopus 로고
    • Phototherapy for atopic dermatitis
    • Krutmann J. Phototherapy for atopic dermatitis. Clin Exp Dermatol. 7:2000;552-558.
    • (2000) Clin Exp Dermatol , vol.7 , pp. 552-558
    • Krutmann, J.1
  • 24
    • 0033066967 scopus 로고    scopus 로고
    • Long term application of extracorporeal photochemotherapy in severe atopic dermatitis
    • Prinz B., Michelsen S., Pfeiffer C., et al. Long term application of extracorporeal photochemotherapy in severe atopic dermatitis. J Am Acad Dermatol. 40:1999;577-582.
    • (1999) J Am Acad Dermatol , vol.40 , pp. 577-582
    • Prinz, B.1    Michelsen, S.2    Pfeiffer, C.3
  • 25
    • 0021944078 scopus 로고
    • Double-blind crossover study comparing doxepin with dipenhydramine for the treatment of chronic urticaria
    • Green S.L., Read C.E., Schroeter A.L. Double-blind crossover study comparing doxepin with dipenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol. 12:1985;669-700.
    • (1985) J Am Acad Dermatol , vol.12 , pp. 669-700
    • Green, S.L.1    Read, C.E.2    Schroeter, A.L.3
  • 26
    • 0035153505 scopus 로고    scopus 로고
    • The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis
    • Drake L., Pendergast M., Maher M., et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol. 44:2001;S65-72.
    • (2001) J Am Acad Dermatol , vol.44 , pp. 65-72
    • Drake, L.1    Pendergast, M.2    Maher, M.3
  • 27
    • 0034302906 scopus 로고    scopus 로고
    • The effect of antibacterial soap with 1.5% triclocarban on Staphylococcus aureus in patients with atopic dermatitis
    • Breneman D.L., Hanifin J.M., Berge C.A., et al. The effect of antibacterial soap with 1.5% triclocarban on Staphylococcus aureus in patients with atopic dermatitis. Cutis. 66:2000;296-300.
    • (2000) Cutis , vol.66 , pp. 296-300
    • Breneman, D.L.1    Hanifin, J.M.2    Berge, C.A.3
  • 28
    • 0035136487 scopus 로고    scopus 로고
    • The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis
    • Yanase D.J., David-Bajar K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol. 44:2001;89-93.
    • (2001) J Am Acad Dermatol , vol.44 , pp. 89-93
    • Yanase, D.J.1    David-Bajar, K.2
  • 29
    • 0031827317 scopus 로고    scopus 로고
    • The leukotriene antagonist zafrilukast as atherapeutic agent for atopic dermatitis
    • Carucci J.A., Washenik K., Weinstein A., et al. The leukotriene antagonist zafrilukast as atherapeutic agent for atopic dermatitis. Arch Dermatol. 134:1998;785-786.
    • (1998) Arch Dermatol , vol.134 , pp. 785-786
    • Carucci, J.A.1    Washenik, K.2    Weinstein, A.3
  • 30
    • 4244170212 scopus 로고    scopus 로고
    • Bedminister, NJ: FARO Parmaceuticals Inc
    • ® (azathioprine) [package insert]. Bedminister, NJ: FARO Parmaceuticals Inc;1999.
    • (1999) ® (Azathioprine) [Package Insert]
  • 31
    • 0028356607 scopus 로고
    • Manteinance treatment with cyclosporin in adults with severe refractory atopic dermatitis
    • Munro C.S., Levell N.J., Shuster S., et al. Manteinance treatment with cyclosporin in adults with severe refractory atopic dermatitis. Br J Dermatol. 130:1994;376-380.
    • (1994) Br J Dermatol , vol.130 , pp. 376-380
    • Munro, C.S.1    Levell, N.J.2    Shuster, S.3
  • 32
  • 33
    • 0035041745 scopus 로고    scopus 로고
    • Ascomycin: An advance in the management of atopic dermatitis
    • Griffiths C.E.M. Ascomycin an advance in the management of atopic dermatitis . Br J Dermatol. 144:2001;679-681.
    • (2001) Br J Dermatol , vol.144 , pp. 679-681
    • Griffiths, C.E.M.1
  • 34
    • 0033842847 scopus 로고    scopus 로고
    • Treatment of atopic eczema with oral mycophenolate mofetil
    • Neuber K., Schwartz I., Itschert G., et al. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol. 143:2000;385-391.
    • (2000) Br J Dermatol , vol.143 , pp. 385-391
    • Neuber, K.1    Schwartz, I.2    Itschert, G.3
  • 35
    • 0035038185 scopus 로고    scopus 로고
    • Pharmacologic alternative for severe atopic dermatitis
    • DiCarlo J.B., McCall C.O. Pharmacologic alternative for severe atopic dermatitis. Int J Dermatol. 40:2001;82-88.
    • (2001) Int J Dermatol , vol.40 , pp. 82-88
    • Dicarlo, J.B.1    McCall, C.O.2
  • 36
    • 0034069636 scopus 로고    scopus 로고
    • Atopic dermatitis: New insights and opportunities for therapeutic intervention
    • Leung D.Y.M. Atopic dermatitis new insights and opportunities for therapeutic intervention . J Allergy Clin Immunol. 105:2000;860-876.
    • (2000) J Allergy Clin Immunol , vol.105 , pp. 860-876
    • Leung, D.Y.M.1
  • 37
    • 0035141609 scopus 로고    scopus 로고
    • A trial of oolong tea in the management of recalcitrant atopic dermatitis
    • Uehara M., Sugiura H., Sakurai K. A trial of oolong tea in the management of recalcitrant atopic dermatitis. Arch Dermatol. 137:2001;42-43.
    • (2001) Arch Dermatol , vol.137 , pp. 42-43
    • Uehara, M.1    Sugiura, H.2    Sakurai, K.3
  • 38
    • 0033039611 scopus 로고    scopus 로고
    • A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis
    • Fung A.G., Look P.C., Chong L.Y., et al. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol. 38:1999;387-392.
    • (1999) Int J Dermatol , vol.38 , pp. 387-392
    • Fung, A.G.1    Look, P.C.2    Chong, L.Y.3
  • 39
    • 0030798511 scopus 로고    scopus 로고
    • Doxepin cream relieves eczema-associated pruritus within 15 minutes and is not accompanied by a risk of rebound upon discontinuation
    • Breneman D.L., Dunlap F.E., Monroe E.W., et al. Doxepin cream relieves eczema-associated pruritus within 15 minutes and is not accompanied by a risk of rebound upon discontinuation. J Dermatol Treat. 8:1997;161-168.
    • (1997) J Dermatol Treat , vol.8 , pp. 161-168
    • Breneman, D.L.1    Dunlap, F.E.2    Monroe, E.W.3
  • 42
    • 0033783720 scopus 로고    scopus 로고
    • Modulation of the atopy patch test reaction by topical corticosteroids and tar
    • Langeveld-Wildschut E.G., Riedl H., Thepen T. Modulation of the atopy patch test reaction by topical corticosteroids and tar. J Allergy Clin Immunol. 106:2000;737-743.
    • (2000) J Allergy Clin Immunol , vol.106 , pp. 737-743
    • Langeveld-Wildschut, E.G.1    Riedl, H.2    Thepen, T.3
  • 43
    • 0024833459 scopus 로고
    • A comparative trial of clinitar versus hydrocortisone cream in the treatment of eczema
    • Munkvad M. A comparative trial of clinitar versus hydrocortisone cream in the treatment of eczema. Br J Dermatol. 121:1989;763-766.
    • (1989) Br J Dermatol , vol.121 , pp. 763-766
    • Munkvad, M.1
  • 44
    • 0030056483 scopus 로고    scopus 로고
    • Type 4 phoshodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis
    • Hanifin J., Chan S., Cheng J. Type 4 phoshodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol. 107:1996;51-56.
    • (1996) J Invest Dermatol , vol.107 , pp. 51-56
    • Hanifin, J.1    Chan, S.2    Cheng, J.3
  • 45
    • 0033928261 scopus 로고    scopus 로고
    • Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice
    • Kotani M., Matsumoto M., Fujita A., et al. Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J Allergy Clin Immunol. 106:2000;159-166.
    • (2000) J Allergy Clin Immunol , vol.106 , pp. 159-166
    • Kotani, M.1    Matsumoto, M.2    Fujita, A.3
  • 46
    • 84945357421 scopus 로고    scopus 로고
    • D.N. Gilbert, R.C. Moellering, & M.A. Sande. Hyde Park, VT: Antimicrobial Therapy Inc
    • Gilbert D.N., Moellering R.C., Sande M.A. The Sanford Guide to Antimicrobial Therapy, 31 edition. 2001;Antimicrobial Therapy Inc, Hyde Park, VT.
    • (2001) The Sanford Guide to Antimicrobial Therapy, 31 Edition
  • 47
    • 0033678148 scopus 로고    scopus 로고
    • Down regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis
    • Yawalkar N., Karlen S., Egli F., et al. Down regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis. J Allergy Clin Immunol. 106:2000;941-947.
    • (2000) J Allergy Clin Immunol , vol.106 , pp. 941-947
    • Yawalkar, N.1    Karlen, S.2    Egli, F.3
  • 48
    • 0033898753 scopus 로고    scopus 로고
    • Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis
    • The European Tacrolimus Ointment Study Group
    • Reitamo S., Wollenberg A., Schopf E., et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol. 136:2000;999-1006.
    • (2000) Arch Dermatol , vol.136 , pp. 999-1006
    • Reitamo, S.1    Wollenberg, A.2    Schopf, E.3
  • 49
    • 0035157535 scopus 로고    scopus 로고
    • Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy
    • Hanifin J.M., Ling M.R., Langley R., et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients part I, efficacy . J Am Acad Dermatol. 44:2001;S28-38.
    • (2001) J Am Acad Dermatol , vol.44 , pp. 28-38
    • Hanifin, J.M.1    Ling, M.R.2    Langley, R.3
  • 50
    • 0035157895 scopus 로고    scopus 로고
    • Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety
    • Soter N.A., Fleischer A.B., Webster G.F., et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients part II, safety . J Am Acad Dermatol. 44:2001;S39-46.
    • (2001) J Am Acad Dermatol , vol.44 , pp. 39-46
    • Soter, N.A.1    Fleischer, A.B.2    Webster, G.F.3
  • 52
    • 85030933178 scopus 로고    scopus 로고
    • Novartis Pharmaceuticals Corporation
    • Novartis Pharmaceuticals Corporation.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.